Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glaxo Wellcome Production is a major manufacturing subsidiary of GSK, primarily operating out of its large-scale industrial site in Evreux, France. The facility serves as a global center of excellence for respiratory health, specializing in the production of complex inhaled medicines such as dry powder inhalers and pressurized metered-dose inhalers. It is responsible for the high-volume manufacture of iconic GSK brands including Ventolin and the Ellipta range, supplying treatments for asthma and COPD to over 100 markets worldwide. The entity integrates advanced pharmaceutical formulation with sophisticated device assembly and automated packaging. As a critical component of GSK's global supply chain, it operates under stringent Good Manufacturing Practice (GMP) standards and is a leader in developing sustainable, low-carbon inhaler technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glaxo Wellcome Production.